ABSTRACT
Homocysteine (Hcy) is a S-containing amino acid and its plasma concentrations can be raised by various constitutive, genetic and lifestyle factors. Hyperhomocysteinaemia is a modest independent predictor (risk factor or marker) of cardiovascular disease, stroke, neurodegeneration and cancer. 1, 2 Some recent studies have shown that Hcy toxicity is mainly caused by oxidative stress via increasing inflammatory response 3 and augmenting reactive oxygen species (ROS). 4 Hyperhomocysteinemia is related with increased ROS formation, including the superoxide anion radical (O2-) and hydrogen peroxide (H2O2), 5 and in that way it leads to oxidative stress and Copyright © 2019 Djuric et al. This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. cellular damage. 6 Oxidative stress may influence the endogenous antioxidant system that includes glutathione-dependent enzymes (glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione-S-transferase (GST)), superoxide dismutase (SOD), and catalase (CAT) antioxidant enzymes. 6, 7 There is a evidence that hyperhomocysteinemia may impair the glutathione-related antioxidant defense system, 8, 9 however data about its effect on SOD activity are still controversial. Wilcken et al. have revealed a positive correlation between SOD activity and Hcy levels in patients with homocystinuria, 10 while other authors showed that hyperhomocysteinemia decreased erythrocyte SOD activity in patients with cardiovascular disease. 9, 11 On the other hand, there are increasing number of assumptions that signaling gaseous molecules as nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H 2 S) 12 may have an important role in effects of Hcy-thiolactone on the myocardial function and coronary circulation. 13 This is very plausible having in mind that gasotransmitters have an important role in the regulation of inflammation, oxidative stress, modulation of mitochondria respiration and activation of antioxidant enzymes.
14 With participation of NO, S-nitroso-Hcy inhibits hydrogen peroxide.
15
H2S also decreases level of Hcy in plasma 16 and it is strong antioxidant. 17 CO is the most stable gasotransmitter, and it is capable of exerting its effects during long time and distances. 18 However, Hcy-thiolactone and gasotransmitters connection is still not fully understood. Thus, the aim of this research was to examine the effects of acute administration of DL-Hcy alone or in combination with specific inhibitors of different gasotransmitters, such as Nω-nitro-L-arginine methyl ester (L-NAME), Zinc protoporphyrin IX (ZnPPR IX) and DL-Propargyl Glycine (DL-PAG) on oxidative stress markers in the rat plasma -catalase (CAT), superoxide dismutase (SOD), glutatione peroxidase (GPx) activities and malondialdehyde (MDA) concentration.
Physiological Assay and Experimental Protocol
Male Wistar albino rats (n = 96, 12 in each experimental group, 10 weeks old, body weight (250 ± 30 g) have been used for investigation. Animals were housed in strictly controlled conditions (air temperature of 22±1°C, relative humidity of 50%, a cycle of brightness: darkness 12:12 hours, starting bright period at 8 AM), with free access to water and standard food. In all experimental groups, tested substances were administered in a single dose, intraperitoneally (i.p.), 60 minutes before euthanasia of animals. All animals were divided into 8 groups, and received: 1) Control group -saline (1 ml 0.9% NaCl i.p., pH 7.4); 2) DL-Hcy group (8 mmol/kg i.p. DL homocysteine); 3) L-NAME group (10 mg/kg i.p. L-NAME as inhibitor of NO production via inhibition of nitric oxide synthase); 4) ZnPPR IX group (30 µmol/kg i.p. ZnPPR IX as inhibitor of CO production via inhibition of heme oxygenase-1); 5) DL-PAG group (50 mg//kg i.p. DL-PAG as inhibitor of H2S production via inhibition of cystathionine gamma lyase); 6) DL-Hcy+L-NAME group (8 mmol/kg i.p. DL-Hcy + 10 mg/kg i.p. L-NAME); 7) DL-Hcy+ZnPPR IX group (8 mmol/kg i.p. DL-Hcy + 30 µmol/kg i.p. ZnPPR IX), and DL-Hcy+DL-PAG group (8 mmol/kg i.p. DL-Hcy + 50 mg//kg i.p. DL-PAG).
All experimental procedures were done in accordance with prescribed legislation (EU Directive for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes 86/609/EES) and the principles of ethics.
Biochemical analyses
Sixty minutes after administration of tested substances, the rats were euthanized by decapitation. Blood was collected through a glass funnel and placed in test tubes coated in heparin. The blood samples were left at the room temperature for 15 min and afterwards centrifuged (15 min×3000 rpm). The obtained plasma was used for the analyses.
The evaluated parameters were determined in the control condition, and then in acute series of experiments.
Determination of Hcy
The plasma samples were analyzed using the electrochemiluminescence method (ECL-electrochemiluminescence immunoassay system, ADVIA Centaur XP System, Siemens Healthcare GmbH, Erlangen, Germany); the range of reference values was Hcy< 15 µmol/l.
METHODS

Determination of lipid peroxidation products (MDA)
MDA content in plasma was determined by using of thiobarbituric assay.
14 500 ml of 25% HCl and 500 ml of 1% thiobarbituric acid (in 50 mM NaOH) was added in 500 ml of sample. The mixture was heated for 10 minutes on boiling water bath, and cooled to room temperature. Then 3 mL of n-butanol was added and shaken on a Vortex for 30 seconds. In order to successfully separate phases, samples are centrifugated (10 minutes at 2000 × g). Content of malondialdehyde was determined spectrophotometrically by measuring the absorbance of the organic phase (upper layer) at 532 nm. The blanks contain 50 mM NaOH instead of thiobarbituric acid, and they are prepared for each sample separately. The values of MDA content (nmol of MDA/ml plasma) was determined on the basis of absorbance values and molar absorption coefficient of the malondialdehyde-thiobarbituric acid complex.
Determination of CAT activity
CAT activity was measured by an essay that accompanies the degradation of H2O2 according to Beutler. 19 50 µl of a suspension of plasma was added to the quartz glass tubes at room temperature, consisting of 2.975 ml of 50 mM phosphate buffer solution in 0.4 mM EDTA. The enzyme reaction is initiated by adding 30 µl of 3% H2O2. Reduction in absorbance due to enzymatic degradation of H2O2 (at 240 nm for 3-5 minutes) was monitored. CAT activity was expressed as U/ml of plasma. One unit (U) of enzyme activity was defined as 1 micromol of spent H2O2/min.
Determination of SOD activity
The activity of total SOD was measured according to the method of Misra and Fridovich.20 10-30 µl of plasma was added in 3 ml of a 0.5 M EDTA-sodium carbonate buffer (pH 10.2). The enzymatic reaction started by adding 100 ml of epinephrine (30 mM in 0.1 M HCl). SOD activity was measured at absorbance of 480 nm during 4 minutes. One unit (U) of SOD was defined as the amount of enzyme that inhibits the rate of the epinephrine oxidation for 50%. The enzyme activity was expressed as U/ml of plasma.
Determination of GPx activity
Procedure for measuring of GPx activity begins with preparation of reaction cocktail which consists of 8.9 ml of phosphate buffer, 50 µl of 200 mM reduced glutathione (GSH), 1 mg of β-NA-DPH, and 100 ml of 100 units/ml GSH-reductase from baker's yeast (Saccharomyces cerevisiae). pH value of reaction cocktail was adjusted to 7 (50 mM NaH2PO4 + 0.40 mM EDTA). 3 ml of a reaction cocktail and 0.3 ml of plasma sample was added in a quartz glass cuvette (room temperature). Cuvette was placed in a spectrophotometer, and 50 ml of 0.042% H2O2 was added in order to start enzymatic reaction (A240 = 0.52 to 0.56). The decline of absorbance (λ = 340 nm) in intervals of 15 seconds during the 4-5 minutes was monitored. GPx activity was expressed as ΔA/min/ml of plasma. 21 .
Chemicals used
All chemicals were of p.a. grade quality and were purchased from Sigma Aldrich (Germany).
Statistical analyses
The parameters of descriptive statistics were used. For testing statistical significance after testing normality of distribution, one-way analysis of variance (ANOVA), followed by Tukey's Post Hoc Test was used. Statistical calculation was done using SPSS computer program (SPSS Inc. Chicago, SАD). Values are presented as mean ± SEM. P < 0.05 was considered statistically significant.
RESULTS
Determination of Hcy
In all plasma samples levels of measured Hcy were more than 65 µmol/l, indicating moderate hyperhomocysteinemia (30-100 µmol/l), except in the Control group in which it was 10.4 ± 0.6 µmol/l.
Plasma MDA values
In all experimental groups: DL-Hcy (6.09±0.85 nmol/ml of plasma, Figure 1 . a), L-NAME (5.63±0.85 nmol/ml of plasma, Figure 1 . a), DL-PAG (5.28±1.37 nmol/ml of plasma, Figure 1 . a), DL-Hcy+L-NAME (4.10±0.74 nmol/ml of plasma, Figure 1 . b), DL-Hcy+ZnPPR IX (4.28±0.59 nmol/ml of plasma, Figure 1 . b), DL-Hcy+DL PAG (9.90±0.94 nmol/ml of plasma, Figure 1 . b), except ZnPPR IX alone (17.30±4.74 nmol/ ml of plasma, Figure 1. a) , the administration of tested substances induced significant decrease in MDA values compared with control condition (15.37±1.41 nmol/ml of plasma) (Figure 1 a, b) .
Plasma CAT activity
In relation to control group (16.40±2.11 U/ml of plasma, Figure 2. a, b) , the administration of all 
Plasma GPx activity
Levels of GPx were significantly increased by all of the applied substances: L-NAME (3.37±0.23 U/ml of plasma, Figure 3 . a), ZnPPR IX (4.50±0.13 U/ml of plasma, Figure 3 . a), DL-PAG (7.91±0.80 U/ml of plasma, Figure 3 . a), DL-Hcy+L-NAME (7.60±0.77 U/ml of plasma, Figure 3 . b), DL-Hcy+ZnPPR IX (12.59±0.69 U/ml of plasma, Figure 3 . b), DL-Hcy+DL-PAG (6.37±0.72 U/ml of plasma, Figure 3 . b), except DL-Hcy alone (1.76±0.28 U/ml of plasma, Figure 3 . a), compared with control condition (1.09±0.14 U/ml of plasma, Figure 3. a, b) .
Plasma SOD activity
Administration of all tested substances: DLHcy (30.41±0.71 U/ml of plasma, Figure 4 . a), L-NAME (31.07±0.40U/ml of plasma, Figure 4 
DISCUSSION
In present investigation DL-Hcy caused decrease of MDA level in the plasma, indicating that acutely applied Hcy does not increase lipid peroxidation in plasma of rats. Similar results were observed in case of NO or H2S inhibition, or during synergistic application of each inhibitor with Hcy. Therefore, we can assume that (except CO) gaseous molecules could induce plasma lipid peroxidation, while in presence of Hcy positive effect of their blockage seems to be even more obvious. Decreased level of MDA in all groups may be consequence of increased activities of antioxidant enzymes in same groups during the same time. We previously noted that thiolactone form of Hcy alone or in combination with gasotransmitter inhibitors non-significantly decreased level of lipid peroxidation measured in coronary venous effluent. significantly increased levels of GPx in the same groups. It seems logic, considering that GPx by reducing H2O2 level, inhibit lipid peroxidation directly or indirectly by mediation of lipid peroxides. 23 During inhibition of gasotransmitter production, it has been observed increased activity of plasma antioxidant enzymes, indicating that NO, CO or H2S could react with these enzymes in plasma. However, during inhibition of gaseous signaling molecules production, Hcy continues to potentiate raise in activity of SOD, CAT and GPx. These results showed no changes in dynamics of measured plasma antioxidants in presence or in absence of gasotransmitter synthesis alone, suggesting that the influences of Hcy are not quite clear. At the end, it is important to emphasize that determination of each gasotransmitter effect was assessed indirectly by their inhibition of production, which could be limitation of this study also. Addition of any data on mRNA and also cellular data would provide more evidence to the notion that enzyme involved in oxidative stress are induced or suppressed.
CONCLUSION AUTHORSHIP STATEMENT
Gasotransmitters inhibitors increased significantly antioxidant enzymes activities and that increase was higher when they were administered in combination with Hcy. This indirectly indicates that gasotransmitters have an important role in oxidative stress protection.
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